| 104683-8 | 1,1-Dimethoxyoctadecane (DMA 18:0) (Dbs) | CHEM |
| 104684-6 | 1,1-Dimethoxy-(9Z)octadecene (DMA 18:1) (Dbs) | CHEM |
| 104685-3 | 1,1-Dimethoxyhexadecane (DMA 16:0)/palmitate (C16:0) (Dbs) | CHEM |
| 104686-1 | 1,1-Dimethoxyoctadecane (DMA 18:0)/Octadecanoate (C18:0) (Dbs) | CHEM |
| 104687-9 | Dimethylacetal (DMA) panel - DBS | PANEL.CHEM |
| 104688-7 | Measles, mumps, rubella and varicella-zoster virus Ab.IgG panel - Serum or Plasma | PANEL.MICRO |
| 104689-5 | Egg White IgE Panel - Serum | PANEL.ALLERGY |
| 10469-5 | Carcinoembryonic Ag (Tissue, qualitative, immune stain) | PATH |
| 104690-3 | Bivalirudin in Platelet poor plasma (chromogenic method) | COAG |
| 104691-1 | Clofazimine+Amikacin (minimum inhibitory concentration (mic)) | ABXBACT |
| 104692-9 | oxyMORphone (oral fluid) (Saliva, qualitative, screen method) | DRUG/TOX |
| 104693-7 | Ethyl glucuronide (oral fluid) (Saliva, qualitative, screen method) | DRUG/TOX |
| 104694-5 | CD40 cells (Blood, qualitative, flow cytometry (fc)) | CELLMARK |
| 104695-2 | Aminoacylase-1 deficiency panel - Urine | PANEL.CHEM |
| 104696-0 | N-acetylglycine/Creatinine (Urine) | CHEM |
| 104697-8 | N-acetyl-L-alanine/Creatinine (Urine) | CHEM |
| 104698-6 | N-acetyl-L-glutamate/Creatinine (Urine) | CHEM |
| 104699-4 | N-acetyl-L-methionine/Creatinine (Urine) | CHEM |
| 1047-0 | H NOS Ab (qualitative) | BLDBK |
| 10470-3 | Choriogonadotropin Ag (Tissue, qualitative, immune stain) | PATH |
| 104700-0 | Platelet clump (qualitative) | HEM/BC |
| 104701-8 | Blood smear finding | HEM/BC |
| 104702-6 | Rhinovirus+Enterovirus RNA in Specimen (qualitative, molecular genetics method) | MICRO |
| 104703-4 | Medication non-substitution reason | MEDS |
| 104704-2 | Acanthocytes (qualitative) | HEM/BC |
| 104705-9 | Platelets (qualitative) | HEM/BC |
| 104706-7 | Mycoplasma pneumoniae DNA in Specimen (qualitative, molecular genetics method) | MICRO |
| 104707-5 | Medication safety override Narrative | MEDS |
| 104708-3 | Estimated average glucose (Blood) | CHEM |
| 104709-1 | Parainfluenza virus 1 RNA in Specimen (qualitative, molecular genetics method) | MICRO |
| 10471-1 | Chromogranin A Ag (Tissue, qualitative, immune stain) | PATH |
| 104710-9 | Target cells (qualitative) | HEM/BC |
| 104711-7 | Parainfluenza virus 3 RNA in Specimen (qualitative, molecular genetics method) | MICRO |
| 104712-5 | Human coronavirus NL63 RNA in Specimen (qualitative, molecular genetics method) | MICRO |
| 104713-3 | Stomatocytes (qualitative) | HEM/BC |
| 104714-1 | Hepatitis C virus RNA (molecular genetics method) | MICRO |
| 104715-8 | Hepatitis C virus RNA (qualitative, molecular genetics method) | MICRO |
| 104716-6 | Parainfluenza virus 4 RNA in Specimen (qualitative, molecular genetics method) | MICRO |
| 104717-4 | Medication name Medication | MEDS |
| 104718-2 | Elliptocytes (qualitative) | HEM/BC |
| 104719-0 | Direction repetition timing | CLIN |
| 10472-9 | Chromogranin Ag (Tissue, qualitative, immune stain) | PATH |
| 104720-8 | Clinical indication Narrative | CLIN |
| 104721-6 | Hepatitis C virus RNA (molecular genetics method) | MICRO |
| 104722-4 | Chlamydia trachomatis rRNA in Specimen (qualitative, molecular genetics method) | MICRO |
| 104723-2 | Medication role | MEDS |
| 104724-0 | Streptococcus agalactiae DNA in Specimen (qualitative, molecular genetics method) | MICRO |
| 104725-7 | Medication overridden safety advice Medication Narrative | MEDS |
| 104726-5 | Dacrocytes (qualitative) | HEM/BC |
| 104727-3 | Influenza virus A H1 2009 pandemic RNA in Specimen (qualitative, molecular genetics method) | MICRO |